Search

everythinglearnresearchcommunity

for

Search:↓

Clinical signs of hyperandrogenism are related to female pattern hair loss severity, but biochemical markers are not.

PSA could be a marker for hyperandrogenism in women, but more research is needed.

Low iron, low thyroid function, and stress are linked to excessive hair shedding in women.

Spironolactone helps reduce hair growth in women with hirsutism but may cause menstrual irregularities.

"Male-pattern" hair loss is common in women, especially after menopause, and doesn't always mean there's a problem with hormone balance.

Diffuse alopecia in women may be related to androgens and iron deficiency, and basic hormone and nutrient screening is useful.

A 5 mg dose of transdermal testosterone cream effectively restores testosterone levels in postmenopausal women.

Testosterone therapy can modestly improve sexual function in menopausal women but should be used cautiously and is not recommended for routine measurement in sexual dysfunction or hirsutism.

New hormonal contraceptives are safer, have fewer side effects, and offer health benefits for women.

Testosterone implants in women require pharmacological dosing to be effective and are generally safe and well-tolerated.

Increasing sleep by 41 minutes daily for a month showed no significant changes in metabolism or hormone levels in healthy women.

Male hormones may play a role in the development of heart disease, and more research is needed to understand their effects.

High androgen levels in Chinese women with PCOS are linked to a higher risk of diabetes and obesity.

Women with female pattern hair loss have higher levels of certain androgens, suggesting increased androgen exposure to hair follicles.

Hair loss in women linked to higher sexual dysfunction risk.

Some women with excess hair growth have a hormone condition that can't be diagnosed by blood or urine tests alone.

The study concluded that low iron and vitamin D levels in women might play a role in chronic hair loss, despite no significant difference between those with and without hair loss.

The main cause of hirsutism in Algerian women is polycystic ovary syndrome, and those affected should be checked for related hormonal issues.

Hormonal therapies like cyproterone acetate and spironolactone may help some women with hair loss, but finasteride 1mg is not useful, and the effectiveness of other treatments is still unclear.

Some conditions mimic PCOS symptoms and need careful diagnosis to treat potentially serious health issues.

Rasayana therapy can enhance female reproductive health at different life stages.

Female pattern hair loss is common and should be treated early to prevent worsening, with Minoxidil being the main approved treatment.

Drinking alcohol before taking flibanserin does not increase the risk of severe low blood pressure or fainting.

Primary care is key in managing PCOS, focusing on lifestyle changes and medications like birth control and metformin.

Frontal Fibrosing Alopecia's cause is unclear, affects mainly postmenopausal women, and current treatments focus on stopping hair loss rather than regrowth.

No treatment has been proven to effectively stop hair loss or regrow hair in Frontal Fibrosing Alopecia, and more research is needed.

Doctors should recognize and treat PCOS early in primary care to manage symptoms and lower risk of other health issues.

Eating well and exercising can help manage PCOS symptoms.

Sertoliform endometrioid carcinoma of the ovary, though rare, has a good prognosis when treated early.

Flibanserin may help improve sexual symptoms in various conditions beyond its approved use.